Blue Spoon is First to Publish System-Level Framework for Innovation by the Pharmaceutical Industry
/EINPresswire.com/ NEW YORK, NY June 22, 2010 - Blue Spoon Consulting today published a system-level framework for innovation by the pharmaceutical industry. Available as a briefing note for download through the Blue Spoon Consulting website (www.bluespoonconsulting.com) A New Orbit for Innovation shifts the premise of strategy itself, from an 'experience curve' based on how best to develop and market drug brands, to the idea of a 'collaboration curve' based on novel linkages to create new health and economic value. This is a whole new model to improve strategic performance, unlock "next practice" business concepts, and reorganize the industry around a value proposition that goes beyond the domain of drug.
Blue Spoon is a leading strategy consultancy serving the global pharmaceutical, healthcare, and telecommunications industries. The firm is pioneering 'system-level competition', an approach to growth and innovation that reshapes the terms of competition in markets, industries, and economic sectors. Blue Spoon is the only consultancy in the world with a methodology to design and manage industry ecosystems. Visit: www.bluespoonconsulting.com.
Blue Spoon is a leading strategy consultancy serving the global pharmaceutical, healthcare, and telecommunications industries. The firm is pioneering 'system-level competition', an approach to growth and innovation that reshapes the terms of competition in markets, industries, and economic sectors. Blue Spoon is the only consultancy in the world with a methodology to design and manage industry ecosystems. Visit: www.bluespoonconsulting.com.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.